PS PeptideSuppliers.org Finding the right peptide supplier for you
AOD-9604 reference image
View supplier listing 15% off with code PPL15
Peptide guide

AOD-9604 Peptide Guide & Supplier Listing Notes

Modified fragment of human GH 176-191

GH fragment / metabolic research

GLP and metabolic research compounds Educational guide Supplier transparency
Back to directory Compare supplier pages

Research Areas

The main research domains where this compound appears most often.

The main research area for AOD-9604 is fat metabolism. Early studies examined lipolysis, lipogenesis, fat oxidation, and body-weight changes in obese animal models.

A second research area is growth hormone biology. AOD-9604 helps illustrate how different regions of a hormone may contribute to different biological effects.

AOD-9604 is also relevant to anti-doping and analytical chemistry because it has appeared in sports-drug testing literature. Detection and metabolism studies help define how the compound is identified in laboratory contexts.

Animal studies

What preclinical work has emphasized

Most of AOD-9604's strongest evidence comes from animal studies. Obese mouse and rat models have examined body weight, body fat, lipolytic sensitivity, and fat oxidation after treatment with hGH fragments.

These studies support mechanistic interest, but they do not prove human weight-loss outcomes. Animal obesity models differ from human metabolic disease, and route, dose, and study duration affect interpretation.

Human studies

How much human evidence exists

Human evidence for AOD-9604 is more limited and less definitive than its public popularity suggests. The compound is widely discussed online, but research pages should avoid implying that early animal findings establish human weight-loss efficacy.

A balanced human-studies section should state that AOD-9604 has a clearer preclinical and mechanistic research profile than a robust modern clinical evidence base.

Current research status

Where the research stands now

AOD-9604 remains common in peptide discussions, but its scientific identity is best defined by early metabolic and hGH-fragment research. Current interest includes fat metabolism, analytical detection, and comparison with other GH-axis compounds.

The biggest gap in the literature is human evidence. claims narrow and avoid presenting AOD-9604 as equivalent to GLP-1 compounds or clinically established obesity therapies.

Browse suppliers Open peptide directory Read education guides Best peptide suppliers

Related Compounds

Closely related compounds frequently discussed within the same research category.

Growth hormone is the biological source context. Tesamorelin, sermorelin, and CJC-1295 are related through GH-axis discussions but work differently. IGF-1 LR3 is related downstream in growth-factor biology. Metabolic compounds such as semaglutide or tirzepatide may be compared by users, but their mechanisms are completely different.

Tesamorelin Sermorelin CJC-1295 MOTS-c
Supplier considerations

How to read supplier pages more carefully

AOD-9604 listings should clearly identify the compound as an hGH fragment and include batch-specific COAs. Researchers should look for purity data, identity testing, lot numbers, storage instructions, and research-use labeling. Supplier pages should avoid implying that AOD-9604 has the same evidence base as GLP-1 medications or clinically established metabolic therapies.

  • Look for batch-specific COAs instead of generic laboratory files reused across many listings.
  • Check whether the product name, concentration language, and batch references stay consistent from page to page.
  • Read storage and handling notes alongside the document links rather than treating the headline purity claim as enough.
  • Prefer supplier pages that keep research-use labeling, contact details, and policy pages easy to verify.

Linked supplier pages

Supplier pages that help compare naming, documentation access, batch references, and overall page clarity.

Supplier listing

Pinnacle Peptide Labs

This listing helps with checking naming, documentation access, storage language, and overall page clarity.

View supplier listing
15% off with code PPL15

Frequently Asked Questions

Common questions drawn from the published literature and documentation context.

What is AOD-9604?

AOD-9604 is a synthetic fragment derived from the C-terminal region of human growth hormone.

Is AOD-9604 a GLP-1 peptide?

No. It is a growth hormone fragment, not an incretin compound.

What is AOD-9604 studied for?

It is studied for lipolysis, fat oxidation, adipose tissue biology, and metabolic effects in experimental models.

Does AOD-9604 stimulate growth hormone release?

No. It is not a GH secretagogue like sermorelin, CJC-1295, or ipamorelin.

Does AOD-9604 have human research?

Human evidence is limited compared with preclinical studies.

Why is AOD-9604 controversial online?

It is often marketed with broad weight-loss claims that exceed the strongest available evidence.

What compounds are related to AOD-9604?

Growth hormone, tesamorelin, CJC-1295, sermorelin, and IGF-1 LR3 are related through GH-axis discussions.

What should researchers check when comparing suppliers?

COAs, peptide identity, purity data, storage guidance, and research-use labeling.

References

Primary sources and clinical references cited in this overview.